IUPAC-induced computational approaches for identifying boosters of small biomolecule functionality: A case study of human tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors
This paper introduces several proof-of-concept (PoC) computational methods intended to offer biochemical researchers straightforward, time- and cost-effective strategies to accelerate their work. While Machine Learning (ML) models were developed, the study's central purpose was to explore approaches for the identification of desirable functional groups/fragments in small biomolecules regarding a specific functionality, which, in this case, was human tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibition. This was achieved primarily by tokenising IUPAC names to generate features. Additionally, the applicability of the CID_SID ML model for predicting TDP1 activity was developed and explored. Since these computational approaches were not experimentally validated due to a lack of appropriate laboratory facilities, they are presented as open proposals for further laboratory investigation.
Authors
- Mariya L. Ivanova (ORCID: https://orcid.org/0009-0005-7730-2423)
- Konstantin Nikolić (ORCID: https://orcid.org/0000-0002-6551-2977)
- Nicola Russo (ORCID: https://orcid.org/0000-0002-6379-0287)
- Gueorgui Mihaylov
Institutions
- University of West London (GB)
- Halton General Hospital (GB)
Publication Details
- Journal
- Computers in Biology and Medicine
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1016/j.compbiomed.2026.111531
- Citations
- 1
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 45.17